Jay Venkatesan

Track

Insider profile

Currently holds positions in Alpine Immune Sciences Inc and Exicure Inc

Performance

Overall performance
3.5
Performance over holding periods
3.5
30 days 90 days 120 days
Average return 9% 8.2% 15.1%
Success rate 82% 68% 82%
Transactions
9 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director Alpine Immune Sciences Inc Aug. 1, 2018 -
Independent Director Exicure Inc March 1, 2014 -
President, Director Alpine Immune Sciences Inc July 24, 2017 - Aug. 1, 2018
Executive Vice President, General Manager Cascadian Therapeutics Inc Aug. 1, 2014 - Jan. 1, 2015
Jay Venkatesan's trades of AgeX Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-22 2026-05-22
B Purchase
82,446 +2.7%
183.29
US$2,958,982 		82,446 +2.7% 183.29 US$2,958,982
2022-05-27 2022-05-25
B Purchase
6,657 -6.9%
301.30
US$2,430,470 		6,657 -6.9% 301.30 US$2,430,470
2022-05-25 2022-05-24
B Purchase
28,545 -23.5%
73.32
US$4,991,244 		28,545 -23.5% 73.32 US$4,991,244
2022-05-25 2022-05-20
B Purchase
50,000 +3.1%
1.23
US$61,500 		50,000 +3.1% 1.23 US$61,500
2021-12-22 2021-12-20
B Purchase
3,527 +0.3%
2.54
US$8,976 		3,527 +0.3% 2.54 US$8,976
2021-12-20 2021-12-17
B Purchase
13,742 +1.0%
2.54
US$34,958 		13,742 +1.0% 2.54 US$34,958
2021-12-20 2021-12-16
B Purchase
27,883 +2.1%
2.55
US$70,993 		27,883 +2.1% 2.55 US$70,993
2021-12-17 2021-12-15
B Purchase
77,604 +6.3%
2.41
US$186,956 		77,604 +6.3% 2.41 US$186,956
2021-02-11 2021-02-09
S Sale
159,177 -11.6%
16.00
US$2,546,832 		159,177 -11.6% 16.00 US$2,546,832
2019-08-06 2019-08-02
US Exicure Inc (XCUR)
B Purchase
250,000 +478.6%
2.00
US$500,000 		250,000 +478.6% 2.00 US$500,000
2019-01-22 2019-01-18
B Purchase
190,875 +5.0%
5.37
US$1,024,999 		190,875 +5.0% 5.37 US$1,024,999
2017-09-28 2017-09-26
US Exicure Inc (XCUR)
B Purchase
66,666 +73.9%
3.00
US$199,998 		66,666 +73.9% 3.00 US$199,998